Search results for Head and Neck Cancer.
Found 22 clinical studies.
Cancer Related Cognitive Impairment (Crci) And Its Relationship To Specific Types Of Changes In Thinking And Other Medical Conditions
- Investigator: Rhonna Shatz
- Posted Date: Apr 18, 2024
- Type of Study: Observational/Survey
Assessment Of The Efficacy And Efficiency Of An Educational Video In The Consent Process For Radiation Treatment Of Head And Neck Cancer Patients
- Investigator: Bailey Nelson
- Posted Date: Apr 24, 2023
- Type of Study: Observational/Survey
Cell Culture Of Patient-Derived Primary Vocal Fold
- Investigator: Gregory Dion
- Posted Date: Feb 20, 2023
- Type of Study: Observational/Survey
Swallowing Disparities In Oropharyngeal Squamous Cell Carcinoma (Opscc)
- Investigator: David Rule
- Posted Date: Jan 31, 2023
- Type of Study: Observational/Survey
Pro-Active: Comparing The Effectiveness Of Prophylactic Swallow Intervention For Patients Receiving Radiotherapy For Head And Neck Cancer
- Investigator: Brittany Krekeler
- Posted Date: Sep 19, 2022
- Type of Study: Observational/Survey
Evaluation Of Complicated Living Grief In Head And Neck Cancer Patients And Survivors
- Investigator: Rachael Nolan
- Posted Date: Feb 15, 2022
- Type of Study: Observational/Survey
A Phase 1/2, Open-Label, First-In-Human Study To Evaluate The Safety And Anti-Tumor Activity Of Fs118, A Lag-3/Pd-L1 Bispecific Antibody, In Patients With Advanced Malignancies
- Investigator: Christopher Lemmon
- Posted Date: Oct 28, 2021
- Type of Study: Drug
A Pilot Study Of Pembrolizumab And Lenvatinib Combination Therapy In Patients With Previously Treated Advanced Gastroesophageal Adenocarcinoma
- Investigator: Davendra Sohal
- Posted Date: Oct 19, 2021
- Type of Study: Drug
Debio1143-Scchn-301- A Randomized, Double-Blind Placebo-Controlled, Phase 3 Study Of Debio 1143 In Combination With Platinum-Based Chemotherapy And Standard Fractionation Intensity-Modulated Radiotherapy In Patients With Locally Advanced Squamous Cell Car
- Investigator: Trisha Wise-Draper
- Posted Date: May 5, 2021
- Type of Study: Drug
Mk-7902-009-A Phase 2, Randomized, Open-Label Three-Arm Clinical Study To Evaluate The Safety And Efficacy Of Lenvatinib (E7080/Mk-7902) In Combination With Pembrolizumab (Mk-3475) Versus Standard Of Care Chemotherapy And Lenvatinib Monotherapy In Partici
- Investigator: Christopher Lemmon
- Posted Date: May 5, 2021
- Type of Study: Drug
Uccc-Hn-20-01- Phase 1B/II Trial Combining Pd1 Inhibition (Pembrolizumab) And Cesium 131 Brachytherapy With Salvage Surgery To Enhance Immunogenicity And Improve Local Control In Head And Neck Cancer
- Investigator: Chad Zender
- Posted Date: May 5, 2021
- Type of Study: Device & Drug
R1216- Randomized Phase II/III Trial Of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, Or Cisplatin-Atezolizumab In Pathologic High-Risk Squamous Cell Cancer Of The Head And Neck
- Investigator: Sara Medek
- Posted Date: Jan 18, 2021
- Type of Study: Drug
Uccc-Hn-20-02- Evaluation Of Complicated Living Grief In Head And Neck Cancer Patients And Survivors
- Investigator: Chad Zender
- Posted Date: Jan 18, 2021
- Type of Study: Observational/Survey
Ea3132- Phase II Randomized Trial Of Radiotherapy With Or Without Cisplatin For Surgically Resected Squamous Cell Carcinoma Of The Head And Neck (Scchn) With Tp53 Sequencing
- Investigator: Trisha Wise-Draper
- Posted Date: Oct 26, 2020
- Type of Study: Drug
J2g-Mc-Jzjb- A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing Loxo-292 To Physicians Choice Of Cabozantinib Or Vandetanib In Patients With Progressive, Advanced, Kinase Inhibitor Naïve, Ret-Mutant Medullary Thyroid Cancer
- Investigator: Trisha Wise-Draper
- Posted Date: Mar 4, 2020
- Type of Study: Drug
Nrg-Hn005- Randomized Phase II And Phase III Studies Of Individualized Treatment For Nasopharyngeal Carcinoma Based On Biomarker Epstein Barr Virus (Ebv) Deoxyribonucleic Acid (Dna)
- Investigator: Vinita Takiar
- Posted Date: Nov 7, 2019
- Type of Study: Drug
Immune Related Adverse Events Following Checkpoint Inhibitors
- Investigator: Eric Vick
- Posted Date: Oct 14, 2019
- Type of Study: Observational/Survey
Ea3163- Phase II Randomized Trial Of Neo-Adjuvant Chemotherapy Followed By Surgery And Post-Operative Radiation Versus Surgery And Post-Operative Radiation For Organ Preservation On T3 And T4a Nasal And Paranasal Sinus Squamous Cell Carcinoma (Npnscc
- Investigator: Vinita Takiar
- Posted Date: Oct 1, 2019
- Type of Study: Observational/Survey
Clinical Outcomes In Endocrine Disease
- Investigator: Tammy Holm
- Posted Date: Jun 11, 2019
- Type of Study: Observational/Survey
Ucci-Hn-17-02 An Open-Label, Phase II Study Of Durvalumab (Medi4736) In Combination With Cetuximab In Previously Treated Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma (Hnscc)
- Investigator: Trisha Wise-Draper
- Posted Date: May 20, 2019
- Type of Study: Drug
Nrg-Hn001- Randomized Phase II And Phase III Studies Of Individualized Treatment For Nasopharyngeal Carcinoma Based On Biomarker Epstein Barr Virus (Ebv) Deoxyribonucleic Acid (Dna)
- Investigator: Jordan Kharofa
- Posted Date: May 15, 2019
- Type of Study: Drug
Nrg-Hn004- Randomized Phase II/III Trial Of Radiotherapy With Concurrent Medi4736 (Durvalumab) Vs. Radiotherapy With Concurrent Cetuximab In Patients With Stage III-Ivb Head And Neck Cancer With A Contraindication To Cisplatin
- Investigator: Vinita Takiar
- Posted Date: May 15, 2019
- Type of Study: Drug